Available methods for benefit-risk assessment: lessons for inflammatory bowel disease drugs. Caron B, D'Amico F, Jairath V, Netter P, et al. J Crohns Colitis 2022 Aug 11. pii: 6661406. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Caron B, D'Amico F, Jairath V, Netter P, et al. Available methods for benefit-risk assessment: lessons for inflammatory bowel disease drugs. J Crohns Colitis 2022 Aug 11. pii: 6661406. doi: 10.1093.
PMID: 35952722